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ﺬﻨﻣﺎﻴﻘﻳﺮﻓﺃﻭﺎﻴﺳﺁﻦﻣﺔﻨﻴﻌﻣﻖﻃﺎﻨﻣﻲﻓﺕﺎﺟﻼﻌﻛﻞﺑﻹﺍﻝﺍﻮﺑﺃﻭﻥﺎﺒﻟﺃﺖﻣﺪﺨُﺘﺳﺍ
ﻢﻋﺍﺰﻤﻟﺍﻚﻠﺗﻑﺎﺸﻜﺘﺳﺎﺑﺎﻣﺎﻤﺘﻫﺍﺀﺎﻤﻠﻌﻟﺍﻯﺪﺑﺃﻂﻘﻓﺎﺜﻳﺪﺣﻦﻜﻟﻭ٬ﺔﻤﻳﺪﻗﺔﻨﻣﺯﺃ
ﺕﺎﺳﺍﺭﺪﻟﺍﺾﻌﺑﻭﺔﻳﺮﺒﺨﻤﻟﺍﺔﻟﺩﻷﺍﻦﻣﺩﺪﻋﺮﻴﺸﻳ.ﻞﺑﻹﺍﺕﺎﺠﺘﻨﻤﻟﺔﻴﺟﻼﻌﻟﺍ
ﻞﺑﻹﺍﻝﺍﻮﺑﺃﻊﻣﺔﺟﻭﺰﻤﻣﺕﻻﺎﺤﻟﺍﺾﻌﺑﻲﻓﻭ٬ﺎﻫﺪﺣﻭﻞﺑﻹﺍﻥﺎﺒﻟﺃﻥﺃﻰﻟﺇﺔﻳﺮﻳﺮﺴﻟﺍ
ﺔﻴﺳﺎﺴﺣﻭ٬ﻥﺎﻃﺮﺴﻟﺍﻭ٬ﻱﺮﻜﺴﻟﺍﺀﺍﺩﻞﺜﻣﺔﻋﻮﻨﺘﻣﺔﻳﺮﻳﺮﺳﺕﻻﺎﺣﺝﻼﻋﻲﻓﺔﻟﺎّﻌﻓ
ﻦﻣﻯﺮﺧﺃﺔﻋﻮﻤﺠﻣﻭﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺍﻭ٬ﺪﺣﻮﺘﻟﺍﺽﺮﻣﻭ٬ﺔﻤﻌﻃﻷﺍ
ﻦﻣﺩﺪﻋﻑﺎﺸﺘﻛﺍﻢﺗ٬ﻚﻟﺫﻰﻟﺇﺔﻓﺎﺿﻹﺎﺑ.ﺔﻴﻠﻴﻔﻄﻟﺍﻭﺔﻳﺮﻴﺘﻜﺒﻟﺍﻭﺔﻴﺳﻭﺮﻴﻔﻟﺍﺕﺎﺑﺎﺻﻹﺍ
٬ﺔﻳﻮﻣﺪﻟﺍﺔﻴﻋﻭﻷﺍﻭﺐﻠﻘﻟﺍﺯﺎﻬﺟﻰﻠﻋﻞﺑﻹﺍﻝﺍﻮﺑﺃﻭﻥﺎﺒﻟﻷﺔﻠﻤﺘﺤﻤﻟﺍﺔﻴﺟﻼﻌﻟﺍﺭﺎﺛﻵﺍ
ﻞﺜﻤﻳﻲﻟﺎﺤﻟﺍﺽﺮﻌﻟﺍ.ﻦﻳﺮﺒﻳﺎﻔﻠﻟﺐﻳﺬﻤﻟﺍﻭﺔﻳﻮﻣﺪﻟﺍﺢﺋﺎﻔﺼﻠﻟﺩﺎﻀﻤﻟﺍﺎﻬﻠﻤﻋﺔﺻﺎﺨﺑﻭ
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management of diverse clinical conditions such as dia-
betes mellitus, cancer, food allergy, autism, viral hepatitis
and a host of other viral, bacterial and parasitic in-
fections. In addition, a number of potential benefits of
camel milk and urine on the cardiovascular system,
particularly their antiplatelet and fibrinolytic actions,
have been demonstrated. The current review presents a
concise summary of the scientific evidence to support
these therapeutic actions.
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The one-humped camel (Camelus dromedaries) is a unique
animal that survives and reproduces under severe climatic
conditions of heat and drought that do not suit the survival
of other species of domestic mammals. For desert dwellers in
Asia and Africa, the camel continues to be vital to daily life
as a source of food and a means of transportation, and just as
importantly, its milk and urine have been used as medicines
for diverse ailments since ancient times.1,2 However,his is an open access article under the CC BY-NC-ND license
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began identifying specific diseases and medical conditions
that have been treated by camel milk or urine, including
cancer,3 chronic hepatitis,4 hepatitis C infection5,6 and
peptic ulcers.7 Even more recently, it has been reported
that camel milk has cured severe food allergies in children
who were unresponsive to conventional treatments8 and
diabetes mellitus.9 Furthermore, camel milk is endowed
with anti-malignant,10 antiplatelet11 and anti-thrombotic
properties12 in addition to a host of anti-bacterial and viral
properties,13,14 suggesting, among other things, the existence
of a very strong immune system, which was recently shown to
be equipped with unique light-chain-only antibodies.15
These claimed therapeutic actions have recently been the
subject of numerous studies, and there is now mounting
scientific information detailing the constituents of camel milk
and urine as well as their therapeutic components. These
revelations lend scientific evidence to support the current
practice of using these camel products for their therapeutic
benefits. The following review summarizes the current
knowledge in these areas.Anti-diabetic action of camel milk
Diabetes mellitus (DM) is characterized by abnormally
high blood glucose levels, resulting from low insulin secretion
and/or increased insulin resistance.16 DM and its
complications have become a main focus of interest for
researchers worldwide due to their close association with
the risk of cerebrovascular and cardiovascular disorders,
which were noted in 68% of diabetes-related deaths among
patients aged 65 years or older.17,18 Today, the management
of DM remains a great challenge for treating physicians.
In addition to the conventional diabetic management
strategies of diet, insulin, oral hypoglycaemic drugs, and
exercise, diabetes has also received attention because of the
current wide interest in alternative therapies for chronic
incurable diseases. In this respect, there is mounting evidence
that camel milk (CM) consumption is effective in the control
of DM in both humans9,19e21 and experimental animals.22,23
Strong support for this notion comes from camel breeders in
India who consume CM regularly and who have zero
incidence of DM compared to 5.5 percent in other
communities in which CM is not consumed.20 Additional
support comes from the more recent finding that the
consumption of CM by type I diabetic patients resulted in
a 30e35% reduction in the daily insulin requirements, with
significant decreases in both blood glucose levels and
micro-albuminuria.9
These benefits can be related in part to the unique
composition of CM, which is rich in insulin, insulin-like
proteins,24 minerals, immunoglobulins25 and trace elements
with anti-inflammatory properties. Additionally, CM pos-
sesses antioxidants and free radical scavengers.26e28 Further,
camel insulin possesses unique features that make it different
from human and other animal insulin and more effective
when orally administered. Camel insulin, unlike the insulin
contained within other animal and human milks, is
contained within micelles and is thus protected from
digestion and proteolysis in the upper gastrointestinal tract;
it has also been proposed that camel insulin is encapsulatedin nanoparticles that facilitate its absorption and easy
passing to the blood stream.24 An added advantage of
camel milk consumption by diabetic patients was
discovered in recent renal functional and genetic studies in
diabetic animals showing that camel milk has renal
protection actions that prevent the renal damage associated
with diabetes, as it attenuates the biochemical and
morphological features of diabetic nephropathy in these
diabetic animals.26 It is also plausible that the antioxidant
action of CM prevents the manifestations of metabolic
syndrome, including hyperglycaemia, hyperlipidaemia, and
insulin resistance. This, in turn, would inhibit the
pathophysiological processes underlying the microvascular
complications of DM, including retinopathy, nephropathy
or cardiovascular complications that heighten the mortality
and morbidity of the disease.9,21,28
The above findings lend strong support to the beneficial
effect of CM as a nutritional supplement and therapeutic
adjuvant in the management of DM. In addition to the
established hypoglycaemic benefit, CM treatment is expected
to achieve the nephrologists’ goal of renal protection.Anti-cancer action of camel milk
The claimed anti-cancer action of camel products is
widely accepted by local healers who use of a mixture of
camel milk and urine in the treatment of patients suffering
from a variety of cancers, including breast, nasopharyngeal,
lung and others. This, in addition to the difficulties faced by
modern medicine in finding a lasting cure for cancer,
prompted the current flurry of studies attempting to find
evidence to support these claimed anti-cancer actions of
camel milk and urine and eventually succeed in identifying
the anti-malignant component in camel milk or urine that
could ultimately lead to the discovery of an effective anti-
cancer drug.
In a series of in vitro experiments, a research group led by
Dr Fatin Khorshid succeeded in demonstrating that lyoph-
ilized camel urine stopped the growth of tumour cells
implanted into experimental animals and the growth of
malignant cell lines including hepatocellular carcinoma
(HEPG2), colon carcinoma (HCT 116), human glioma
(U251) cells, lung cancer cells and leukaemic cells. She sug-
gested that this anti-cancer action could be both a direct cell
cytotoxicity and cutting blood supply to tumour cells, i.e.,
anti-angiogenic action.29e32 The latter action of camel urine
was recently confirmed by our group. In a series of recent
experiments we have demonstrated that both camel urine33
and milk,34 each on its own, inhibited inflammatory
angiogenesis in the murine sponge implant angiogenesis
model. Further support for the anti-cancer action of camel
urine comes from the observations of Alhaider et al.35 that
camel urine causes significant inhibition of the expression
of the gene encoding carcinogen-activating enzyme Cyp1a1
at the mRNA level in cancerous liver cells. Similar, apoptotic
anti-cancer action has also been demonstrated in camel
milk.36 To date, the exact nature of the anti-malignant con-
stituents in camel milk or urine have not been identified,
although the iron binding, multi-tasking and multi-
functional protein lactoferrin (LF) is believed to be a
possible candidate.37
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found that the administration of LF along with chemotherapy
resulted in better prognosis than chemotherapy alone38 and
that LF inhibited the growth of adenomatous colorectal
polyps in human patients.39 In line with these revelations,
LF has also been shown to be directly cytotoxic against
cancer cells by inducing the inhibition of the proliferation
of cancer cells and their subsequent programmed cells death
(apoptosis).40 Detailed evidence drawn from laboratory and
clinical studies on the actions of LF, which were reviewed
recently,41 have confirmed that the ingestion of LF resulted
in the inhibition of tumour growth and induced apoptosis
and the metastasis of tumour cells by both anti-angiogenic
and cytotoxic actions. However, almost all of these studies
were performed using the commercially available bovine
LF, with the exception of a few in which camel LF was
used.27 Therefore, further research is needed to confirm these
findings using camel LF, which is reported to be more potent
than bovine LF.27
Finally, it is becoming clear that the local healers’ practice
of prescribing milk along with urine has a double advantage
as both products are endowed with anti-cancer actions;
additionally, the milk disguises the identity and taste of the
urine and makes its consumption palatable to the patient.
Chronic hepatitis and hepatitis C infection
The early observations of Sharmanov et al., in 19824 were
the first to suggest an anti-viral action of camel milk when
they found that camel’s milk was more effective than mare’s
milk in improving and normalizing the clinical and
biochemical status of patients with chronic active hepatitis.
Later observations using camel urine therapy in patients with
Bilharzial liver disease supported this finding, as significant
improvement was noted in the clinical condition of these
patients with marked resolution of the ascites and morpho-
logical changes of the cirrhotic liver.42 Subsequent studies
have shown that camel lactoferrin markedly inhibits
hepatitis C virus genotype 4 infection of human peripheral
blood leukocytes and that the incubation of human
leucocytes with camel LF followed by their infection with
HCV prevented the entry of the virus into the cells. The
conclusion was that the direct interaction between the
HCV and camel LF led to complete inhibition of virus
entry into the cells; in this respect camel lactoferrin proved
to be a more potent anti-viral agent than bovine and hu-
man lactoferrins.5 Additionally, camel milk administration
clears Schistosoma Mansoni from infected mice, thereby
indicating a further beneficial anti-parasitic action of camel
milk.43
Food allergies and other therapeutic benefits of camel milk
In addition to the diseases described above, numerous
small studies have reported diverse therapeutic benefits of
camel milk. For example, a group of children with severe
food (mainly milk) allergies who failed to respond to all
modern therapies recovered fully after the daily administra-
tion of camel milk.8 This finding confirms further the unique
immune properties of camel milk, which are also believed to
be the basis for its efficacy in the treatment of viral andbacterial infections.14 Relevant to the immune properties of
camel milk, camel whey protein was shown to be effective
in enhancing wound healing in the diabetic mouse model
by mobilizing a wide range of cellular immune responses as
well as cytokines.44,45
Camel milk supplementation was reported to cause sig-
nificant improvement in the clinical symptoms and investi-
gative tests of patients suffering from drug-resistant
tuberculosis.46 Similar therapeutic benefit was also shown
in children with autism (autism spectral disorders,
ASD).47e49 The consumption of CM by sufferers of
autism resulted in the disappearance of autism symptoms
in some cases or caused significant improvement in these
symptoms; patients became quieter and less destructive
and showed better emotional expression and
communication.
Finally, recent studies from our laboratory have shown
that camel milk and urine possess potent cardiovascular
actions. In separate in vitro experiments, it was shown
that camel urine has potent platelet blocking properties
similar to the actions of the widely used anti-platelet
drugs, aspirin and clopidogrel.11 An earlier study50 has
shown that lactoferrin isolated from sheep and human
lactoferrin inhibit thrombin-induced aggregation; howev-
er, we could not confirm this observation using human
lactoferrin. Our ongoing efforts are approaching the
identification of the probable dual-platelet inhibitor in
camel urine.
Conversely, camel milk was also shown to have potential
thrombolytic action, as it causes marked reduction in plasma
fibrinogen in diabetic rats.12 The significance of this
observation, added to the observed antiplatelet action
mentioned above, provides strong support for the claimed
anti-cancer properties of camel milk and urine, as the inhi-
bition of coagulation and fibrin formation would hinder the
spread and growth of metastatic tumour cells. These and
other reported benefits of camel milk and urine were drawn
from small laboratory studies and should trigger engagement
in larger controlled trails in patients.The possible therapeutic candidate(s) in camel milk
Judging by the currently accumulated scientific evidence,
there are two possible candidates: Lactoferrin and Camel
Immunogloloulins.Lactoferrin
Camel milk is rich in lactoferrin with potent anti-
microbial and anti-inflammatory properties, including
bacterial inhibition (Staphylococcus aureus, Escherichia coli,
Klebsiella pneumoniae, clostridium and Helicobacter pylori),
antiviral effects (HBC,CMV, herpes simplex virus-1, and
human immunodeficiency virus (HIV, the virus responsible
for AIDS)), antifungal effects (Candida albicans), immu-
nosupportive and immunomodulating functions (regulates
the maturation and activation of neutrophils and macro-
phages), the maturation and function of lymphocytes
(antioxidant and anti-inflammatory) and anti-cancer
actions.27,37
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The medicinal properties of both camel milk and urine
could also be related to the gamma globulins and other im-
mune components, including immunoglobulins, present in
both products.25,51 For example, half of the circulating
antibodies in camel blood consist of only two heavy chains
and no light chains.15 Because of their reduced size, one-
tenth the size of human antibodies, these antibodies can
readily pass to the milk of the lactating camel, can pass the
blood brain barrier, can be filtered in urine, and are readily
absorbed from the gut into the general circulation of con-
sumers of camel milk and/or urine. In addition, the single
antigen-binding domains (VHH) of these heavy-chain anti-
bodiesdalso known as nanobodiesdmay have applications
in cancer diagnosis and therapy and biosensor develop-
ment.52 Recently, the unique features of the camel immune
system and its possible health benefits to humans has been
put into practical use by a Belgian biotechnology company
(Ablynx nv, Technologiepark, 219052, Ghent/Zwijnaarde,
Belgium) that is using animals of the camelid family
(camels and Llama) as the source of targeted immune
therapy for cancer and other autoimmune disease such as
multiple sclerosis and Alzheimer’s disease.
Additionally, it is important to add that reports of the
therapeutic benefits associatedwith bovinemilk consumption
add credibility to the idea that camel milk would have similar
benefits. Bovine milk proteins are known to serve as pre-
cursors for numerous biologically active peptides encrypted
within major milk proteins, and these are activated by
gastrointestinal digestion or food processing.53 Bovine milk
peptides have also been shown to exhibit antimicrobial,
antioxidant, antithrombotic, antihypertensive, and
immunomodulatory actions.54,55
As to the cardiovascular action of camel urine11,56
mentioned above, the identity of the dual human platelet
inhibitor with actions similar to both aspirin and
clopidogrel is being studied, and these efforts are
approaching their conclusion in our centre. Although this
platelet inhibitory activity was observed in camel urine,
earlier studies identified this activity in camel plasma,57,58
where it was thought to be a natural defence mechanism
against thrombotic disease, which camels are at risk to
develop due to excessive exposure to environmental heat
and drought.59
Finally, while knowledge about camels was traditionally
restricted to limited geographical areas, particularly Asia,
Africa and Australia, the use of camel’s milk as a nutrient
and for its health benefits was further confined to only
certain Asian and African countries. Cow’s milk, conversely,
has been consumed worldwide. However, as cross-cultural
migration of humans increased during the 20th century,
knowledge about camels and their milk started to reach
countries beyond Asia and Africa. This culminated in 2013
when the European Community licenced the importation of
camel milk from the United Arab Emirates (UAE). The main
and perhaps only current supplier of camel milk is the Dubai-
based Emirates Industry for Camel Milk and Products
(EICMP), which manufactures its trademark camel milk,
Camelicious, which is now on sale in numerous European
countries, particularly The Netherlands, Denmark andEngland. Another chocolate manufacturer, Al Nassma, is
selling its camel milk chocolate in London’s world-famous
upscale department store Harrods. This increased popu-
larity of camel milk among Europeans is likely due to the
prior knowledge of the unique nutritional value and possible
health benefits of camel milk compared to the more widely
consumed cow’s milk.
Conclusion
The long-standing practice of using camel milk and urine
for medicinal purposes in the Middle East, parts of Africa
and Asia, and the former Soviet Union was without scientific
rationale for centuries. However, based on the existing in-
formation about bovine milk as a functional food, camel
milk, in a similar way, could serve not only as a source of
nutrients but also as a source of bioactive agents with ther-
apeutic properties. The current scientific evidence for the
therapeutic actions of camel milk continues to unfold, and
efforts are underway to more precisely identify the thera-
peutic constituents. Thus, the camel is already proving to be
‘a goldmine’ for researchers.
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